Skip to main content

Table 5 Relation between HCC recurrence and different parameters in group II

From: Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

 

HCC recurrence

Test of Sig.

p

No (n = 19), no. (%)

Yes (n = 31), no. (%)

Focal lesion

 1

10 (52.6%)

23 (74.2%)

χ2 = 2.583

p = 0.227

 2

6 (31.6%)

5 (16.1%)

 3

3 (15.8%)

3 (9.7%)

Overall size (cm)

 Min.–Max.

2.20–8.0

1.30–7.50

t = 1.653

0.105

 Mean ± SD

4.10 ± 1.64

3.40 ± 1.32

 Median

4.0

3.0

BCLC

 0

2 (7%)

0 (0.0%)

χ2=

0.075

 A

7 (36.8%)

19 (61.3%)

 B

10 (52.6%)

12 (38.7%)

HCC treatment

 Hepatic resection

7 (36.8%)

5 (16.1%)

χ2 = 3.207

p = 0.049

 RFA

11 (57.8%)

24 (77.4%)

χ2 = 3.311

0.069

 Alcohol injection

1 (5.2%)

2 (6.5%)

χ2 = 0.543

0.461